Labelling of human platelet α2-adrenoceptors with the full agonist [3H](−)adrenaline
- 1 May 1986
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 124 (1-2) , 31-41
- https://doi.org/10.1016/0014-2999(86)90121-4
Abstract
No abstract availableThis publication has 32 references indexed in Scilit:
- Biochemical and Functional Evidence of Supersensitive Platelet α2-Adrenoceptors in Major Affective DisorderArchives of General Psychiatry, 1986
- Effects of α2‐adrenoceptor agonists and of related compounds on aggregation of, and on adenylate cyclase activity in, human plateletsBritish Journal of Pharmacology, 1984
- Reagents for catecholamine receptor studiesTrends in Pharmacological Sciences, 1983
- Enhanced α2-adrenoceptor-mediated platelet aggregation in patients with major depressive disorderEuropean Journal of Pharmacology, 1983
- Platelet α2-Adrenergic Receptors in Major Depressive DisorderArchives of General Psychiatry, 1981
- α2-adrenoreceptors on human platelets: Selective labelling by [3H]clonidine and [3H]yohimbine and competetive inhibition by antidepressant drugsEuropean Journal of Pharmacology, 1981
- Influence of clonidine-like hypotensive drugs on adrenergic platelet reactionsBiochemical Pharmacology, 1981
- Radioligand Binding Studies of Adrenergic Receptors: New Insights into Molecular and Physiological RegulationAnnual Review of Pharmacology and Toxicology, 1980
- Characterization of the Human Platelet α-Adrenergic ReceptorJournal of Clinical Investigation, 1978
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973